Ezelarab, H.; Abbas, S.; Abourehab, M.; Badr, M.; Sureram, S.; Hongmanee, P.; Kittakoop, P. Abuo-Rahma G, Hassan H. Novel Antimicrobial Ciprofloxacin-Pyridinium Quaternary Ammonium Salts with Improved Physicochemical Properties and DNA Gyrase Inhibitory Activity. Med Chem Res. 2021, 30, 2168-2183.

27 Sep 2021
0
0

Ezelarab, H.; Abbas, S.; Abourehab, M.; Badr, M.; Sureram, S.; Hongmanee, P.; Kittakoop, P. Abuo-Rahma G, Hassan H. Novel Antimicrobial Ciprofloxacin-Pyridinium Quaternary Ammonium Salts with Improved Physicochemical Properties and DNA Gyrase Inhibitory Activity. Med Chem Res. 2021, 30, 2168-2183.

Tags

Share this

Related Posts

Keeratichamroen, S.; Lirdprapamongkol, K.; Thongnest, S.; Boonsombat, J.; Chawengrum, P.; Sornprachum, T.; Sirirak, J.; Verathamjamras, C.; Ornnork, N.; Ruchirawat, S.; Svasti, J. JAK2/STAT3-Mediated Dose-dependent Cytostatic and Cytotoxic Effects of Sesquiterpene Lactones from Gymnanthemum extensum on A549 Human Lung Carcinoma Cells. J. Oncol. Rep. 2022, 47(1), 6. https://doi.org/10.3892/or.2021.8217
01 Jan 2022
0

Keeratichamroen, S.; Lirdprapamongkol, K.; Thongnest, S.; Boonsombat, J.; Chawengrum, P.; Sornprachum, T.; Sirirak, J.; Verathamjamras, C.; Ornnork, N.; Ruchirawat, S.; Svasti, J. JAK2/STAT3-Mediated Dose-dependent Cytostatic and Cytotoxic Effects of Sesquiterpene Lactones from Gymnanthemum extensum on A549 Human Lung Carcinoma Cells. J. Oncol. Rep. 2022, 47(1), 6. https://doi.org/10.3892/or.2021.8217

Keeratichamroen, S.; Lirdprapamongkol, K.; Thongnest, S.; Boonsombat, J.; Chawengrum, P.; Sornprachum, T.; Sirirak, J.; Verathamjamras, C.; Ornnork, N.; Ruchirawat, S.; Svasti, J. JAK2/STAT3-Mediated Dose-dependent Cytostatic and Cytotoxic Effects of Sesquiterpene Lactones from Gymnanthemum extensum on A549 Human Lung Carcinoma Cells. J. Oncol. Rep. 2022, 47(1), 6. https://doi.org/10.3892/or.2021.8217
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More